Quotient Sciences Quotient Sciences

X

List of Certificates of Suitability (CEPs) for MolPort-000-883-800 Active Pharmaceutical Ingredient issued by the EDQM and listed on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
180
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2013-263 - Rev 00
Valid
Chemical
2019-02-07
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2010-302 - Rev 01
Valid
Chemical
2018-11-20
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Germany
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2012-064 - Rev 00
Withdrawn by Holder
Chemical
2013-10-16
2018-03-07
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
CEP 2010-162 - Rev 08
Valid
Chemical
2024-01-04
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2007-052 - Rev 00
Valid
Chemical
2013-07-09
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-104 - Rev 00
Valid
Chemical
2022-03-15
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2020-050 - Rev 01
Withdrawn by Holder
Chemical
2022-03-09
2022-04-28
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
CEP 2009-361 - Rev 06
Valid
Chemical
2024-03-18
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2019-089 - Rev 02
Valid
Chemical
2023-04-21
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Slovenia
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2011-317 - Rev 05
Valid
Chemical
2023-08-07
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Slovenia
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2005-222 - Rev 02
Withdrawn by Holder
Chemical
2016-10-13
2018-04-03
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2013-041 - Rev 00
Valid
Chemical
2020-06-11
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
CEP 2019-344 - Rev 01
Valid
Chemical
2024-01-23
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Israel
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2005-239 - Rev 04
Valid
Chemical
2020-11-27
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2019-159 - Rev 00
Valid
Chemical
2020-11-30
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2008-298 - Rev 02
Valid
Chemical
2020-04-02
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

DSM Anti-Infectives B.V. Delft NL

Contact Supplier
Flag Gabon
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
R0-CEP 2008-276 - Rev 00
Withdrawn by Holder
Chemical and TSE
2010-09-08
2010-12-01
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
R1-CEP 2012-308 - Rev 02
Valid
Chemical
2021-10-22
1700
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
left grey arrow
right gray arrow
  • CAPSULE;ORAL - 250MG
  • TABLET;ORAL - 500MG
  • FOR SUSPENSION;ORAL - 200MG/ML

Looking for 128794-94-5 / Mycophenolate Mofetil API manufacturers, exporters & distributors?

Mycophenolate Mofetil manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Mycophenolate Mofetil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mycophenolate Mofetil manufacturer or Mycophenolate Mofetil supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mycophenolate Mofetil manufacturer or Mycophenolate Mofetil supplier.

PharmaCompass also assists you with knowing the Mycophenolate Mofetil API Price utilized in the formulation of products. Mycophenolate Mofetil API Price is not always fixed or binding as the Mycophenolate Mofetil Price is obtained through a variety of data sources. The Mycophenolate Mofetil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mycophenolate Mofetil

Synonyms

128794-94-5, Cellcept, 115007-34-6, Rs 61443, Myfenax, Rs-61443

Cas Number

128794-94-5

Unique Ingredient Identifier (UNII)

9242ECW6R0

About Mycophenolate Mofetil

Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION.

MolPort-000-883-800 Manufacturers

A MolPort-000-883-800 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-000-883-800, including repackagers and relabelers. The FDA regulates MolPort-000-883-800 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-000-883-800 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of MolPort-000-883-800 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

MolPort-000-883-800 Suppliers

A MolPort-000-883-800 supplier is an individual or a company that provides MolPort-000-883-800 active pharmaceutical ingredient (API) or MolPort-000-883-800 finished formulations upon request. The MolPort-000-883-800 suppliers may include MolPort-000-883-800 API manufacturers, exporters, distributors and traders.

click here to find a list of MolPort-000-883-800 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

MolPort-000-883-800 CEP

A MolPort-000-883-800 CEP of the European Pharmacopoeia monograph is often referred to as a MolPort-000-883-800 Certificate of Suitability (COS). The purpose of a MolPort-000-883-800 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MolPort-000-883-800 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MolPort-000-883-800 to their clients by showing that a MolPort-000-883-800 CEP has been issued for it. The manufacturer submits a MolPort-000-883-800 CEP (COS) as part of the market authorization procedure, and it takes on the role of a MolPort-000-883-800 CEP holder for the record. Additionally, the data presented in the MolPort-000-883-800 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MolPort-000-883-800 DMF.

A MolPort-000-883-800 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MolPort-000-883-800 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of MolPort-000-883-800 suppliers with CEP (COS) on PharmaCompass.

MolPort-000-883-800 Manufacturers | Traders | Suppliers

MolPort-000-883-800 Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY